Brief: Lee's Pharmaceutical Holdings Ltd Sees Net Profit Attributable Of Between Hk$25 Million And Hk$30 Million For Six Months
Lee's Pharmaceutical Holdings Ltd 0950.HK :
* LEE'S PHARMACEUTICAL HOLDINGS LTD SEES NET PROFIT
ATTRIBUTABLE
OF BETWEEN HK$25 MILLION AND HK$30 MILLION FOR SIX MONTHS
* LEE'S PHARMACEUTICAL HOLDINGS LTD - EXPECTED RESULT DUE TO
HIGHER SELLING AND DISTRIBUTION EXPENSES INCURRED IN FIRST HALF
OF 2022, AMONG OTHERS
Source text for Eikon: ID:
Further company coverage: 0950.HK
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA